Cargando...
Cancer immunotherapy with CAR-T cells – behold the future
Cellular therapy is a key tool to treat haematological malignancies. Over 40,000 allogeneic and autologous haematopoietic stem cell transplants (HSCTs) are performed annually across Europe.(1) Since 2017, a new T cell therapy, chimeric antigen receptor-T (CAR-T) cells have been licensed outside clin...
Gardado en:
| Publicado en: | Clin Med (Lond) |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Royal College of Physicians
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6334043/ https://ncbi.nlm.nih.gov/pubmed/30072559 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7861/clinmedicine.18-4-324 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|